Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House committee backs bill to require insurer coverage for histotripsy for certain liver cancers
Summary
The House Insurance Committee reported House Bill 622 favorably with amendments after testimony from a rare-cancer specialist describing histotripsy as a noninvasive liver-directed therapy and insurers and regulators warning about guideline timing and fiscal effects.
House Bill 622, which would require health-insurance coverage for histotripsy procedures in specified cases, was reported favorably from the Louisiana House Insurance Committee on April 29 after testimony from physicians, insurers and regulators.
Representative Sarah Hilferty introduced the bill and said the measure arose after constituent appeals and insurer denials. Hilferty said the procedure can be less invasive and less costly than standard liver surgery and that some patients had been denied access under current insurer medical policies.
Dr. Mary Maluccio, neuroendocrine cancer specialist at East Jefferson General Hospital, described the institution’s experience offering histotripsy. “We have done,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
